Knight Therapeutics (KHTRF) Q4 2023 Earnings

21MarConfirmed
May 22
Aug 22
Nov 22
Q4 2023
-0.17
-0.11
-0.04
0.02

Details

Expected EPS
-0.0088027515
Actual EPS
-0.173535
Surprise EPS
-0.16
Surprise Percent
+1,871.37%

Description

Knight Therapeutics (KHTRF) has reported earnings of -0.173535 per share for Q4 2023.

0 Comments

Share your thoughts